Spa contributes to the virulence of type 18 group a streptococci

D. G.J. McLellan, E. Y. Chiang, Harry Courtney, D. L. Hasty, S. C. Wei, M. C. Hu, M. A. Walls, J. J. Bloom, James Dale

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Streptococcal protective antigen (Spa) is a newly described surface protein of group A streptococci that was recently shown to evoke protective antibodies (J. B. Dale, E. Y. Chiang, S. Liu, H. S. Courtney, and D. L. Hasty, J. Clin. Investig. 103:1261-1268, 1999). In this study, we have determined the complete sequence of the spa gene from type 18 streptococci. Purified, recombinant Spa protein evoked antibodies that were bactericidal against type 18 streptococci, confirming the presence of protective epitopes. Sera from patients with acute rheumatic fever contained antibodies against recombinant Spa, indicating that the Spa protein is expressed in vivo and is immunogenic in humans. To determine the role of Spa in the virulence of group A streptococci, we created a series of insertional mutants that were (i) Spa negative and M18 positive, (ii) Spa positive and M18 negative, and (iii) Spa negative and M18 negative. The mutants and the parent M18 strain (18-282) were used in assays to determine resistance to phagocytosis, growth in human blood, and mouse virulence. The results show that Spa is a virulence determinant of group A streptococci and that expression of both Spa and M18 is required for optimal virulence of type 18 streptococci.

Original languageEnglish (US)
Pages (from-to)2943-2949
Number of pages7
JournalInfection and Immunity
Volume69
Issue number5
DOIs
StatePublished - May 2 2001

Fingerprint

Streptococcus
Virulence
Antibodies
streptococcal protective antigen
Rheumatic Fever
Phagocytosis
Epitopes
Membrane Proteins
Proteins
Growth

All Science Journal Classification (ASJC) codes

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases

Cite this

McLellan, D. G. J., Chiang, E. Y., Courtney, H., Hasty, D. L., Wei, S. C., Hu, M. C., ... Dale, J. (2001). Spa contributes to the virulence of type 18 group a streptococci. Infection and Immunity, 69(5), 2943-2949. https://doi.org/10.1128/IAI.69.5.2943-2949.2001

Spa contributes to the virulence of type 18 group a streptococci. / McLellan, D. G.J.; Chiang, E. Y.; Courtney, Harry; Hasty, D. L.; Wei, S. C.; Hu, M. C.; Walls, M. A.; Bloom, J. J.; Dale, James.

In: Infection and Immunity, Vol. 69, No. 5, 02.05.2001, p. 2943-2949.

Research output: Contribution to journalArticle

McLellan, DGJ, Chiang, EY, Courtney, H, Hasty, DL, Wei, SC, Hu, MC, Walls, MA, Bloom, JJ & Dale, J 2001, 'Spa contributes to the virulence of type 18 group a streptococci', Infection and Immunity, vol. 69, no. 5, pp. 2943-2949. https://doi.org/10.1128/IAI.69.5.2943-2949.2001
McLellan DGJ, Chiang EY, Courtney H, Hasty DL, Wei SC, Hu MC et al. Spa contributes to the virulence of type 18 group a streptococci. Infection and Immunity. 2001 May 2;69(5):2943-2949. https://doi.org/10.1128/IAI.69.5.2943-2949.2001
McLellan, D. G.J. ; Chiang, E. Y. ; Courtney, Harry ; Hasty, D. L. ; Wei, S. C. ; Hu, M. C. ; Walls, M. A. ; Bloom, J. J. ; Dale, James. / Spa contributes to the virulence of type 18 group a streptococci. In: Infection and Immunity. 2001 ; Vol. 69, No. 5. pp. 2943-2949.
@article{6741d7182ac4430586b31f21be06431d,
title = "Spa contributes to the virulence of type 18 group a streptococci",
abstract = "Streptococcal protective antigen (Spa) is a newly described surface protein of group A streptococci that was recently shown to evoke protective antibodies (J. B. Dale, E. Y. Chiang, S. Liu, H. S. Courtney, and D. L. Hasty, J. Clin. Investig. 103:1261-1268, 1999). In this study, we have determined the complete sequence of the spa gene from type 18 streptococci. Purified, recombinant Spa protein evoked antibodies that were bactericidal against type 18 streptococci, confirming the presence of protective epitopes. Sera from patients with acute rheumatic fever contained antibodies against recombinant Spa, indicating that the Spa protein is expressed in vivo and is immunogenic in humans. To determine the role of Spa in the virulence of group A streptococci, we created a series of insertional mutants that were (i) Spa negative and M18 positive, (ii) Spa positive and M18 negative, and (iii) Spa negative and M18 negative. The mutants and the parent M18 strain (18-282) were used in assays to determine resistance to phagocytosis, growth in human blood, and mouse virulence. The results show that Spa is a virulence determinant of group A streptococci and that expression of both Spa and M18 is required for optimal virulence of type 18 streptococci.",
author = "McLellan, {D. G.J.} and Chiang, {E. Y.} and Harry Courtney and Hasty, {D. L.} and Wei, {S. C.} and Hu, {M. C.} and Walls, {M. A.} and Bloom, {J. J.} and James Dale",
year = "2001",
month = "5",
day = "2",
doi = "10.1128/IAI.69.5.2943-2949.2001",
language = "English (US)",
volume = "69",
pages = "2943--2949",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Spa contributes to the virulence of type 18 group a streptococci

AU - McLellan, D. G.J.

AU - Chiang, E. Y.

AU - Courtney, Harry

AU - Hasty, D. L.

AU - Wei, S. C.

AU - Hu, M. C.

AU - Walls, M. A.

AU - Bloom, J. J.

AU - Dale, James

PY - 2001/5/2

Y1 - 2001/5/2

N2 - Streptococcal protective antigen (Spa) is a newly described surface protein of group A streptococci that was recently shown to evoke protective antibodies (J. B. Dale, E. Y. Chiang, S. Liu, H. S. Courtney, and D. L. Hasty, J. Clin. Investig. 103:1261-1268, 1999). In this study, we have determined the complete sequence of the spa gene from type 18 streptococci. Purified, recombinant Spa protein evoked antibodies that were bactericidal against type 18 streptococci, confirming the presence of protective epitopes. Sera from patients with acute rheumatic fever contained antibodies against recombinant Spa, indicating that the Spa protein is expressed in vivo and is immunogenic in humans. To determine the role of Spa in the virulence of group A streptococci, we created a series of insertional mutants that were (i) Spa negative and M18 positive, (ii) Spa positive and M18 negative, and (iii) Spa negative and M18 negative. The mutants and the parent M18 strain (18-282) were used in assays to determine resistance to phagocytosis, growth in human blood, and mouse virulence. The results show that Spa is a virulence determinant of group A streptococci and that expression of both Spa and M18 is required for optimal virulence of type 18 streptococci.

AB - Streptococcal protective antigen (Spa) is a newly described surface protein of group A streptococci that was recently shown to evoke protective antibodies (J. B. Dale, E. Y. Chiang, S. Liu, H. S. Courtney, and D. L. Hasty, J. Clin. Investig. 103:1261-1268, 1999). In this study, we have determined the complete sequence of the spa gene from type 18 streptococci. Purified, recombinant Spa protein evoked antibodies that were bactericidal against type 18 streptococci, confirming the presence of protective epitopes. Sera from patients with acute rheumatic fever contained antibodies against recombinant Spa, indicating that the Spa protein is expressed in vivo and is immunogenic in humans. To determine the role of Spa in the virulence of group A streptococci, we created a series of insertional mutants that were (i) Spa negative and M18 positive, (ii) Spa positive and M18 negative, and (iii) Spa negative and M18 negative. The mutants and the parent M18 strain (18-282) were used in assays to determine resistance to phagocytosis, growth in human blood, and mouse virulence. The results show that Spa is a virulence determinant of group A streptococci and that expression of both Spa and M18 is required for optimal virulence of type 18 streptococci.

UR - http://www.scopus.com/inward/record.url?scp=0035058722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035058722&partnerID=8YFLogxK

U2 - 10.1128/IAI.69.5.2943-2949.2001

DO - 10.1128/IAI.69.5.2943-2949.2001

M3 - Article

VL - 69

SP - 2943

EP - 2949

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 5

ER -